ULTRA-LATE (>24 WEEKS) RESPONSE TO ANTI-CGRP MONOCLONAL ANTIBODIES IN MIGRAINE: A MULTICENTER, PROSPECTIVE, OBSERVATIONAL STUDY

被引：0
|
作者：
Aurilia, C. [1 ]
Egeo, G. [1 ]
Proietti, S. [2 ]
Cevoli, S. [3 ]
Colombo, B. [4 ]
Messina, R. [4 ]
Torelli, P. [5 ]
D'Onofrio, F. [6 ]
Vernieri, F. [7 ]
Altamura, C. [7 ]
Salerno, A. [8 ]
Aguggia, M. [9 ]
Grazzi, L. [10 ]
Trimboli, M. [11 ]
Mercuri, B.
Carnevale, A. [12 ]
Zucco, M. [13 ]
Di Clemente, L. [13 ]
Albanese, M. [14 ]
Finocchi, C. [15 ]
Bono, F. [16 ]
Frediani, F. [17 ]
Filippi, M. [4 ]
Bertuzzo, D.
Favoni, V
Di Fiore, P. [17 ]
Bonassi, S. [2 ,18 ]
Barbanti, P. [18 ]
机构：
[1] Headache & Pain Unit IRCCS San Raffaele Roma, Rome, Italy
[2] Clin & Mol Epidemiol IRCCS San Raffaele Roma, Rome, Italy
[3] IRCCS Ist Sci Neurol Bologna, Bologna, Italy
[4] Univ Vita Salute San Raffaele, Neurol Unit, IRCCS San Raffaele Sci Inst, Milan, Italy
[5] Univ Parma, Unit Neurol, Dept Med & Surg, Headache Ctr, Parma, Italy
[6] San Giuseppe Moscati Hosp, Headache Ctr, Neurol Unit, Avellino, Italy
[7] Policlin Univ, Headache & Neurosonol Unit, Campus Biomed, Rome, Italy
[8] San Giovanni Addolorata Hosp, Headache Ctr, Rome, Italy
[9] Headache Ctr Cardinal Massaia, Asti, Italy
[10] Fdn IRCCS Ist Neurol Carlo Besta, Headache Ctr, Neuroalgol Unit, Milan, Italy
[11] Magna Graecia Univ Catanzaro, Catanzaro, Italy
[12] San Filippo Neri Hosp, Headache Ctr, Rome, Italy
[13] San Camillo Forlanini Hosp, Headache Ctr, Rome, Italy
[14] Univ Hosp Tor Vergata, Reg Referral Headache Ctr, Neurol Unit, Rome, Italy
[15] San Paolo Hosp ASL 2 Savonese, Div Neurol, Savona, Italy
[16] AOU Mater Domini, Ctr Headache & Intracranial Pressure Disorders, Neurol Unit, Catanzaro, Italy
[17] ASST Santi Paolo Carlo, Headache Ctr, Milan, Italy
[18] San Raffaele Univ, Rome, Italy
来源：
HEADACHE | 2023年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P-200
引用
收藏
页码：177 / 178
页数：2
相关论文
共 50 条
  • [41] Personality traits and efficacy of anti-CGRP monoclonal antibodies in migraine prevention
    Carlo Lovati
    Gianna Bernasconi
    Chiara Capogrosso
    Laura Molteni
    Federica Giorgetti
    Bernardo Dell’Osso
    Leonardo Pantoni
    Neurological Sciences, 2022, 43 : 5765 - 5767
  • [42] Efficacy and Safety of Anti-CGRP Monoclonal Antibodies for Migraine Preventative Treatment
    Salim, Amira
    Najjar, Atia
    Ahmed, Zubair
    Mata, Ignacio
    NEUROLOGY, 2023, 100 (17)
  • [43] ANTI-CGRP MONOCLONAL ANTIBODIES FOR NEUROPATHIC PAIN IN PATIENTS WITH MIGRAINE HEADACHE
    Kang, Seung Ah
    Govindarajan, Raghav
    MUSCLE & NERVE, 2020, 62 : S7 - S7
  • [44] Anti-CGRP Monoclonal Antibodies for Neuropathic Pain in Patients with Migraine Headache
    Kang, Seung Ah
    Govindarajan, Raghav
    NEUROLOGY, 2021, 96 (15)
  • [45] Predictors of ≥50% and ≥75% response to anti-CGRP monoclonal antibodies for migraine prevention in real life: results from a european multicenter observational study including 5818 patients
    Caronna, E.
    Gallardo, V. J.
    Alpuente, A.
    Torres-Ferrus, M.
    Huerta Villanueva, M.
    Munoz-Vendrell, A.
    Campoy Diaz, S.
    Obach Baurier, V.
    Fabregat Fabra, N.
    Gago-Viega, A.
    Sanchez Soblechero, A.
    Lozano Ros, A.
    Diaz de Teran, J.
    Membrilla Lopez, J. A.
    Rodriguez-Vico, J. S.
    Guerrero Peral, A. L.
    Garcia Azorin, D.
    Pascual, J.
    Garate, G.
    Cuadrado Godia, E.
    Dorado, L.
    Sanahuja, J.
    Echeverria Urabayen, A.
    Irimia Sieira, P.
    Sanchez del Rio, M.
    Lopez-Bravo, A.
    Alvarez Escudero, R.
    Velasco Juanes, F.
    Santos Lasaosa, S.
    Diaz Insa, S.
    Layos-Romero, A.
    Andres Lopez, A.
    Viguera Romero, J.
    Beltran Blasco, I.
    Gonzalez Oria, C.
    Zapata, S.
    Flores Pina, B.
    Fernandez Lazaro, I.
    Quintas Gutierrez, S.
    Gonzalez Martinez, A.
    Jaimes Sanchez, A.
    Garcia Gomez, A.
    Gonzalez Osorio, Y.
    Gonzalez-Quintanilla, V.
    Kortazar Zubizarreta, I.
    Manera Zorrilla-Lequerica, P.
    Miro Munoz, I.
    Guisado-Alonso, D.
    Oterino Duran, A.
    Riesco Perez, N.
    JOURNAL OF HEADACHE AND PAIN, 2024, 25
  • [46] RE-START STUDY: Multicenter study to assess response after reintroduction of anti-CGRP antibodies in patients with migraine
    Gonzalez Martinez, A.
    Romero del Rincon, C.
    Quintas Gutierrez, S.
    Garcia Azorin, D.
    Fernandez Lazaro, I.
    Guerrero Peral, A. L.
    Gonzalez Osorio, Y.
    Iglesias Diez, F.
    Echavarria Iniguez, A.
    Gil Luque, S.
    Huerta Villanueva, M.
    Campoy Diaz, S.
    Munoz Vendrell, A.
    Velasco Juanes, F.
    Lozano Ros, A.
    Sanchez Soblechero, A.
    Morollon Sanchez-Mateos, N.
    Belvis, R.
    Kortazar Zubizarreta, I.
    Echeverria Urabayen, A.
    Rodrigue-Vico, J. S.
    Jaimes Sanchez, A.
    Gomez Garcia, A.
    Navarro Perez, M. P.
    Montes, N.
    Gago-Viega, A.
    JOURNAL OF HEADACHE AND PAIN, 2024, 25
  • [47] Future prophylactic treatments in migraine: Beyond anti-CGRP monoclonal antibodies and gepants
    Do, T. P.
    Al-Saoudi, A.
    Ashina, M.
    REVUE NEUROLOGIQUE, 2021, 177 (07) : 827 - 833
  • [48] Treatment patterns of patients with migraine eligible for anti-CGRP pathway monoclonal antibodies
    Khodavirdi, Ani C.
    Multani, Jasjit K.
    Oh, Sam S.
    Vuvu, Fiston
    Bensink, Mark E.
    Stockl, Karen M.
    Hawkins, Kevin
    Chiang, Chia-Chun
    Green, A. Laine
    Tepper, Stewart J.
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [49] Blood Pressure in Patients With Migraine Treated With Monoclonal Anti-CGRP (Receptor) Antibodies A Prospective Follow-up Study
    Lentsch, Simone de Vries
    van der Arend, Britt W. H.
    VandenBrink, Antoinette Maassen
    Terwindt, Gisela M.
    NEUROLOGY, 2022, 99 (17) : E1897 - E1904
  • [50] Placebo effects in clinical trials of anti-CGRP monoclonal antibodies for migraine prevention
    Regnier, S.
    Lee, X. Ying
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1):
12345